This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

Making sense of Mendelian randomization

Making sense of Mendelian randomization
Trains leaving from departure station 1 (variant in CRP gene region) pass first through C reactive protein, whereas trains leaving from departure station 2 (variant in IL6R gene region) pass first through interleukin-6 receptor and then branch out either to C reactive protein or directly to the outcome. As variants in the CRP gene region do not associate with the outcome that railway line is blocked by the buffer stop/stopblock. Variants in the IL6R gene region do associate with the outcome, implying that there is a functioning route from departure station 2 to the outcome. However, due to the buffer stop on the route from C reactive protein to the outcome, the effect of interleukin-6 receptor on the outcome must be direct and not via C reactive protein, and hence interleukin-6 receptor is a causal risk factor for coronary heart disease, but C reactive protein is not. Credit: Stephen Burgess and Héléne Toinét Cronjé

Mendelian randomization, a powerful tool in medical research, helps us understand whether certain factors truly cause disease. This technique uses genetic variations as "natural experiments" to reveal cause-and-effect relationships. However, choosing the proper genetic variations is crucial for accurate results.

Think of a train network where the is the starting point, the exposure is a station, and the disease is the destination. The train must pass through the exposure station en route to the disease. This represents the critical assumption of Mendelian randomization: the genetic variation affects the exposure, which then influences the disease.

Biologically motivated approaches are preferred for selecting these genetic variations. They focus on genes directly linked to the exposure, like using variations within a protein-coding gene to understand the protein's impact on disease. This approach is more reliable as it minimizes "off-track" influences on the disease.

Genome-wide analyses, while tempting due to their vast data, can be misleading. They often introduce noise and weaken the signal, leading to unreliable conclusions. Just like having trains going in different directions, these analyses lack the focused direction of biologically motivated approaches.

However, genome-wide analyses can still be helpful as supporting evidence. Imagine having multiple trains starting from different stations but all converging at the exposure station. If these trains consistently reach the disease destination, it strengthens the evidence for a .

  • Making sense of Mendelian randomization
    The instrument variable assumptions imply that all trains leaving the departure station (genetic variant) and arriving at the destination (outcome) must pass through the exposure station. They can take different routes, reflecting different causal pathways, and there can be some pathways from the exposure to unrelated destinations. But the exposure station must be a station stop on all routes from the variant to the outcome. Credit: Stephen Burgess and Héléne Toinét Cronjé
  • Making sense of Mendelian randomization
    Central illustration of factors influencing variant choice in Mendelian randomization. Credit: Stephen Burgess and Héléne Toinét Cronjé

The key takeaway? Prioritize biologically motivated approaches whenever possible. While not always feasible, they offer more precise insights. Genome-wide analyses can be used cautiously for additional support, but their limitations must be considered.

Combining biological understanding with statistical expertise is essential for drawing accurate causal conclusions from Mendelian randomization. This collaboration across disciplines ensures we stay on the right track in understanding the true causes of .

The research is published in the journal eGastroenterology.

More information: Stephen Burgess et al, Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles, eGastroenterology (2024). DOI: 10.1136/egastro-2023-100042

Provided by First Hospital of Jilin University
Citation: Making sense of Mendelian randomization (2024, March 1) retrieved 21 April 2024 from https://medicalxpress.com/news/2024-03-mendelian-randomization.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Anxiety, depression do not cause Meniere disease, or vice versa

0 shares

Feedback to editors